Literature DB >> 6149106

Gastric retention of enteric-coated sulfasalazine tablets. A complication of gastroduodenal Crohn's disease.

A M Harary, C A Gluck, A I Rogers.   

Abstract

A case is described in which a patient with known gastroduodenal Crohn's disease developed a picture of gastric outlet obstruction accompanied by gastric retention of many enteric-coated sulfasalazine tablets. The tablets were removed by gastric lavage with a sodium bicarbonate solution. Following this observation, an in vitro study was done in which the rate of disintegration of enteric-coated sulfasalazine tablets was found to be directly related to pH. The case report reveals a potential hazard in using enteric-coated tablets in patients with impaired gastric emptying. Intragastric sodium bicarbonate may be a useful element in the management of this complication.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6149106     DOI: 10.1007/bf01311262

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  7 in total

1.  Sulphasalazine and salicylazosulphadimidine in ulcerative colitis.

Authors:  J H BARON; A M CONNELL; J E LENNARD-JONES; F A JONES
Journal:  Lancet       Date:  1962-05-26       Impact factor: 79.321

2.  Lavage to remove enteric-coated aspirin and gastric outlet obstruction.

Authors:  M R Sogge; J L Griffith; D R Sinar; G R Mayes
Journal:  Ann Intern Med       Date:  1977-12       Impact factor: 25.391

3.  Relative systemic availability of sulfapyridine from commercial enteric-coated and uncoated sulfasalazine tablets.

Authors:  H J Pieniaszek; D E Resetarits; W W Wilferth; H P Blumenthal; T R Bates
Journal:  J Clin Pharmacol       Date:  1979-01       Impact factor: 3.126

4.  Pyloric stenosis: hold-up of enteric coated aspirin tablets.

Authors:  F C Harris
Journal:  Br J Surg       Date:  1973-12       Impact factor: 6.939

5.  Crohn's disease of the duodenum.

Authors:  F W Nugent; M Richmond; S K Park
Journal:  Gut       Date:  1977-02       Impact factor: 23.059

6.  Sulphasalazine in asymptomatic Crohn's disease. A multicentre trial.

Authors:  J E Lennard-Jones
Journal:  Gut       Date:  1977-01       Impact factor: 23.059

7.  Gastroduodenal Crohn's disease. Differential diagnosis and treatment.

Authors:  A M Harary; A I Rogers
Journal:  Postgrad Med       Date:  1983-12       Impact factor: 3.840

  7 in total
  2 in total

1.  Iatrogenic ileal obstruction in a patient with Crohn's disease.

Authors:  Luca P Piodi; Fabio M Ulivieri; Marina Carini; Angela Piccoli; Maria Teresa Bardella
Journal:  Dig Dis Sci       Date:  2004-08       Impact factor: 3.199

2.  Retention of sulfasalazine tablets.

Authors:  V Garrigues; J Ponce; J Berenguer
Journal:  Dig Dis Sci       Date:  1985-12       Impact factor: 3.199

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.